Equities analysts forecast that Masimo Corporation (NASDAQ:MASI) will announce sales of $188.62 million for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Masimo Corporation’s earnings, with estimates ranging from $187.50 million to $189.41 million. Masimo Corporation posted sales of $167.62 million in the same quarter last year, which would indicate a positive year over year growth rate of 12.5%. The company is expected to report its next earnings results on Wednesday, November 1st.
On average, analysts expect that Masimo Corporation will report full year sales of $188.62 million for the current financial year, with estimates ranging from $769.00 million to $770.50 million. For the next year, analysts expect that the firm will post sales of $824.49 million per share, with estimates ranging from $806.00 million to $838.50 million. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Masimo Corporation.
Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The company had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. During the same quarter in the previous year, the company posted $0.57 earnings per share. The company’s revenue for the quarter was up 11.8% compared to the same quarter last year.
Several research analysts have issued reports on MASI shares. Roth Capital increased their price objective on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. Zacks Investment Research lowered Masimo Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. Stifel Nicolaus started coverage on Masimo Corporation in a research note on Monday, July 10th. They set a “buy” rating and a $105.00 price objective for the company. BidaskClub upgraded Masimo Corporation from a “hold” rating to a “buy” rating in a research note on Wednesday, July 12th. Finally, BTIG Research upgraded Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $95.00.
WARNING: This report was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://ledgergazette.com/2017/09/22/masimo-corporation-masi-expected-to-announce-quarterly-sales-of-188-62-million.html.
Shares of Masimo Corporation (MASI) traded up 0.0590% during trading on Tuesday, hitting $84.9601. 186,936 shares of the stock traded hands. The firm’s 50-day moving average price is $85.78 and its 200-day moving average price is $90.95. Masimo Corporation has a 52 week low of $53.78 and a 52 week high of $104.71. The company has a market cap of $4.41 billion, a price-to-earnings ratio of 13.9256 and a beta of 0.84.
In other news, Director Sanford Fitch sold 14,000 shares of the stock in a transaction on Thursday, June 29th. The stock was sold at an average price of $92.06, for a total transaction of $1,288,840.00. Following the sale, the director now owns 90,249 shares in the company, valued at $8,308,322.94. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Anand Sampath sold 40,000 shares of the stock in a transaction on Tuesday, July 11th. The stock was sold at an average price of $92.00, for a total value of $3,680,000.00. Following the sale, the chief operating officer now owns 20,000 shares in the company, valued at approximately $1,840,000. The disclosure for this sale can be found here. Insiders have sold 126,000 shares of company stock worth $11,732,930 in the last 90 days. Company insiders own 16.60% of the company’s stock.
Several hedge funds have recently made changes to their positions in the company. Fortaleza Asset Management Inc. bought a new position in Masimo Corporation in the second quarter valued at about $106,000. Neuburgh Advisers LLC boosted its holdings in Masimo Corporation by 6.4% in the first quarter. Neuburgh Advisers LLC now owns 1,328 shares of the medical equipment provider’s stock valued at $124,000 after acquiring an additional 80 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Masimo Corporation by 32.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock valued at $166,000 after acquiring an additional 434 shares during the last quarter. Dubuque Bank & Trust Co. boosted its holdings in Masimo Corporation by 3.4% in the second quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after acquiring an additional 61 shares during the last quarter. Finally, Bancorpsouth Inc. bought a new position in Masimo Corporation in the first quarter valued at about $203,000. Institutional investors own 83.21% of the company’s stock.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.